Monserrat Jorge, Angel Sánchez Miguel, de Paz Raquel, Díaz David, Mur Sonia, Reyes Eduardo, Prieto Alfredo, de la Hera Antonio, Martínez-A Carlos, Alvarez-Mon Melchor
Laboratory of Immune System Diseases and Oncology, Department of Medicine (CNB/CSIC Associated Unit), University of Alcalá, Alcala de Henares, 28871, Madrid, Spain; Hematology Service, Hospital Universitario de la Paz, Madrid, Spain.
Cytometry B Clin Cytom. 2013 Jul 29. doi: 10.1002/cytob.21120.
ZAP-70 upregulation in B chronic lymphocytic leukemia (B-CLL) cells is a recognized marker of poor prognosis in these patients; the biological basis of this differential clinical outcome nonetheless remains unknown. ZAP-70 overexpression is considered a surrogate marker of a B-CLL cell subset. To test whether the differential biological characteristics of these patients also include the T helper population, we studied naïve, non-terminated memory (NTEM), terminated memory (TEM) and central memory (CM) cells and cytokine expression by CD4 T lymphocytes from ZAP-70 and ZAP-70 B-CLL patients.
Expression of CD3, CD8, CD45RA, CD27, and CD28 antigens and intracytoplasmic cytokine production (IFNγ, IL-2, IL-4, IL-10 and TNFα) were assessed simultaneously by nine-color flow-cytometry in peripheral blood lymphocytes from B-CLL patients. B cell ZAP-70 expression in B-CLL cells was also analyzed by flow cytometry.
Compared to ZAP-70 B-CLL patients, ZAP-70 B-CLL patients showed 1) significant reduction in the naïve T helper subset and expansion of NTEM and TEM subsets, 2) a decrease in the percentage of activated CD4 T lymphocytes expressing IFNγ, TNFα and IL-2, and 3) an increase in the percentage of CD4 T lymphocytes expressing IL-4 or IL-10.
In conclusion, in early stage B-CLL patients, ZAP-70 upregulation is associated with distinct patterns of activation/differentiation stage subset distribution and of cytokine expression in CD4 T lymphocytes. © 2013 Clinical Cytometry Society.
B 慢性淋巴细胞白血病(B-CLL)细胞中 ZAP-70 的上调是这些患者预后不良的公认标志物;然而,这种不同临床结果的生物学基础仍然未知。ZAP-70 的过表达被认为是 B-CLL 细胞亚群的替代标志物。为了测试这些患者不同的生物学特征是否也包括 T 辅助细胞群,我们研究了 ZAP-70 阳性和 ZAP-70 阴性 B-CLL 患者的初始、未终止记忆(NTEM)、终止记忆(TEM)和中枢记忆(CM)细胞以及 CD4 T 淋巴细胞的细胞因子表达。
通过九色流式细胞术同时评估 B-CLL 患者外周血淋巴细胞中 CD3、CD8、CD45RA、CD27 和 CD28 抗原的表达以及胞内细胞因子的产生(IFNγ、IL-2、IL-4、IL-10 和 TNFα)。还通过流式细胞术分析 B-CLL 细胞中 B 细胞 ZAP-70 的表达。
与 ZAP-70 阴性 B-CLL 患者相比,ZAP-70 阳性 B-CLL 患者表现出:1)初始 T 辅助亚群显著减少,NTEM 和 TEM 亚群扩大;2)表达 IFNγ、TNFα 和 IL-2 的活化 CD4 T 淋巴细胞百分比降低;3)表达 IL-4 或 IL-10 的 CD4 T 淋巴细胞百分比增加。
总之,在早期 B-CLL 患者中,ZAP-70 的上调与 CD4 T 淋巴细胞激活/分化阶段亚群分布和细胞因子表达的不同模式相关。©2013 临床细胞计量学会。